Insmed To Present at the SVB Leerink Virtual 11th Annual Global Healthcare Conference

Rhea-AI Summary

Insmed Incorporated, a biopharmaceutical company focused on serious rare diseases, will present at the SVB Leerink Virtual 11th Annual Global Healthcare Conference on February 18, 2022, at 10:00 a.m. ET. The fireside chat will be available for live viewing on the company’s investor relations website and archived for 30 days post-event. Insmed’s first product targets chronic lung disease, with ongoing research into therapies for neutrophil-mediated inflammatory diseases and rare pulmonary conditions. The company is based in Bridgewater, New Jersey.

BRIDGEWATER, N.J., Feb. 10, 2022 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the SVB Leerink Virtual 11^th Annual Global Healthcare Conference on February 18, 2022 at 10:00 a.m. ET.

The fireside chat will be webcast live and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com. The webcast will be archived for a period of 30 days following the conclusion of the live event.

About Insmed
Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung disease. The Company is also progressing a robust pipeline of investigational therapies targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a growing footprint across Europe and in Japan. For more information, visit www.insmed.com.

Contact:

Investors:

Eleanor Barisser
Associate Director, Investor Relations
Insmed
(718) 594-5332
eleanor.barisser@insmed.com

Media:

Mandy Fahey
Executive Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-present-at-the-svb-leerink-virtual-11th-annual-global-healthcare-conference-301479147.html

SOURCE Insmed Incorporated

FAQ

When will Insmed present at the SVB Leerink Global Healthcare Conference?

Insmed will present at the SVB Leerink Virtual 11th Annual Global Healthcare Conference on February 18, 2022, at 10:00 a.m. ET.

How can I watch Insmed's presentation at the conference?

You can watch Insmed's presentation live on their investor relations website, where it will also be archived for 30 days.

What is Insmed's focus as a biopharmaceutical company?

Insmed focuses on transforming the lives of patients with serious and rare diseases, with products targeting chronic lung disease and ongoing research into inflammatory and pulmonary disorders.

Where is Insmed Incorporated headquartered?

Insmed is headquartered in Bridgewater, New Jersey.